Primobolan is one of the easiest and safest anabolic steroid plans available on the market today. Although this isn’t the typical hormone that many would consider a base steroid for many athletes it does have some excellent benefits when it comes to a supplement for anabolic steroids. Primobolan works especially well when it comes to female athletes as well as for improving performance and physique in conjunction with a base steroid.
Primobolan is generally used for moderate growth or for cutting periods in men and in very small doses however for women it can have some extremely explosive results. Many women use Primobolan in the off-season for mass cultivation and for seeing an enormous athletic gains in short cycles.
When used in conjunction with other steroids Primobolan can bring out the best in all cutting cycles and athletic improvements. Many bodybuilders regularly use it with Anavar, Trenbolone and winstrol to improve cutting power and overall strength. For females in short and concise cycles Primobolan can be extremely beneficial on its own. Many even report that they see massive improvements in athletic power and in bulking when taking moderate doses. Primobolan works better on its own in women but can help men achieve explosive results when they are using other types of steroids.
Most women generally take around 20 to 50 mg per day in a four week on four week off cycle. Men usually introduced between 25 to 50 mg per day when used in conjunction with other steroids in men. It’s important not to dose much higher than 50mg per day as this can lead to permanent hormonal changes that can be difficult to offset with proper PCT.
Women usually benefit more from short and repetitive cycles using Primobolan. Taking it for four weeks on and then taking four weeks off and starting a cycle again seems to create the best possible results. Men on the other hand generally introduce Primobolan into every other cycle with steroids or simply during their cutting phases for the most impactful results.
There are no reviews yet.